Acute Low Back Pain Screening Questionnaire

Abstract

The Acute Low Back Pain Screening Questionnaire (ALBPSQ), subsequently refined and internationally recognized as the Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ), is a premier biopsychosocial clinical assessment instrument designed to identify individuals with acute or subacute low back pain who are at high risk of developing prolonged musculoskeletal disability and persistent work absenteeism. Developed by Steven J. Linton and Kim Halldén in 1998, with significant international validations including the Dutch adaptation by Kole-Snijders and colleagues (2000) and English-language clinical evaluations by Hurley and colleagues (2001), the instrument operationalizes the identification of psychological, social, and functional “yellow flags.” The questionnaire consists of 24 items spanning five distinct psychosocial and functional domains: pain history and duration, pain intensity, psychological distress (depressive mood and anxiety), fear-avoidance beliefs regarding physical activity and work, and self-reported functional limitations in activities of daily living. Items 1 through 3 gather non-scored administrative and demographic data, whereas items 4 through 24 yield numeric scores from 0 (or 1) to 10, producing a theoretical total score ranging from 0 to 210 points. Multiple validation trials establish that total scores exceeding 105 (or 112 in conservative work-disability cohorts) exhibit substantial predictive validity, demonstrating sensitivity values between 70% and 89% and specificity values between 65% and 83% for predicting long-term sick leave at 6 and 12 months. The instrument displays strong psychometric performance, including an overall internal consistency (Cronbach’s alpha) ranging between .82 and .88, and high test-retest reliability with intraclass correlation coefficients (ICCs) between .83 and .94. This article provides a comprehensive academic analysis of the psychometric properties, theoretical foundations, structural validity, clinical utility, scoring algorithms, and full scale composition of the ALBPSQ.

Keywords

Acute Low Back Pain Screening Questionnaire, ALBPSQ, Örebro Musculoskeletal Pain Screening Questionnaire, ÖMPSQ, Psychosocial Yellow Flags, Fear-Avoidance Beliefs, Work Absenteeism, Biopsychosocial Model, Chronic Disability, Prognostic Screening, Psychometrics, Musculoskeletal Disorders.

Authors

The Acute Low Back Pain Screening Questionnaire was primarily formulated and published by Steven J. Linton, Ph.D., and Kim Halldén, M.Sc., affiliated with the Department of Occupational and Environmental Medicine at Örebro University and Örebro Medical Center, Sweden. Dr. Steven J. Linton is an internationally acknowledged authority in clinical psychology and behavioral medicine, extensively recognized for his foundational contributions to understanding psychosocial risk factors, cognitive-behavioral pain management, and secondary prevention of chronic musculoskeletal disability.

Subsequent psychometric cross-validation, standardization, and linguistic translations were conducted by multiple independent research groups. Notable among these is the Dutch adaptation and validation led by A. M. J. Kole-Snijders, W. Sillen, A. Willen, P. H. T. G. Heuts, and Johan W. S. Vlaeyen (2000) from Maastricht University and the Rehabilitation Foundation Limburg (SRL), Hoensbroek, the Netherlands. Johan W. S. Vlaeyen is renowned for co-developing the Fear-Avoidance Model of chronic musculoskeletal pain. In the United Kingdom and Ireland, Deirdre A. Hurley and colleagues (2001) from the School of Physiotherapy, University College Dublin, conducted prominent predictive evaluations establishing the scale’s applicability across primary healthcare and physical therapy environments.

Purpose

The primary clinical and research objective of the Acute Low Back Pain Screening Questionnaire is secondary prevention: specifically, the early detection of patients suffering from acute or subacute episodes of low back pain (≤ 12 weeks duration) who are at high risk of chronicity, prolonged functional impairment, and permanent withdrawal from the labor market. Low back pain represents one of the leading global causes of years lived with disability. While the vast majority of acute episodes resolve spontaneously within four to six weeks, a substantial minority (approximately 10% to 15%) transitions into chronic, recalcitrant conditions accounting for over 80% of total healthcare expenditures and socioeconomic costs associated with back injuries.

Prior to the development of the ALBPSQ, standard medical examinations predominantly focused on biomedical diagnostics, such as spinal imaging, neurological testing, and physical examination of biomechanical pathology. However, extensive clinical epidemiology demonstrated that biomedical indicators (e.g., degenerative disc changes, spinal misalignment, physical range of motion) display exceedingly weak predictive power regarding long-term functional recovery or return to work. In contrast, psychosocial variables—termed “yellow flags”—such as catastrophic thinking, kinesiophobia (fear of movement), depressive symptomatology, passive pain coping, and adverse work-related attitudes, emerged as the most potent determinants of persistent disability.

The ALBPSQ bridges this clinical diagnostic gap by aggregating these disparate psychosocial prognostic factors into a standardized, easily administrable, self-report screening instrument. By administering the tool during the acute presentation (ideally between two to twelve weeks following pain onset), healthcare professionals—including general practitioners, occupational health physicians, physical therapists, and clinical psychologists—can stratify patients into low-, medium-, and high-risk categories. This risk stratification facilitates targeted, stepped-care interventions. Low-risk patients can be managed with minimal clinical intervention, reassurance, and encouragement to maintain ordinary physical activity, thereby avoiding unnecessary medicalization and iatrogenic disability. Conversely, high-risk patients scoring above the clinical threshold can be rapidly triaged to intensive multidisciplinary rehabilitation, cognitive-behavioral physical therapy, and workplace ergonomics consultations designed specifically to deactivate fear-avoidance beliefs and foster adaptive self-regulation.

Psychological Construct

The ALBPSQ does not measure a single, isolated psychological trait. Instead, it measures a multidimensional prognostic composite reflecting an individual’s vulnerability to chronic pain-related disability. This overarching latent construct comprises five primary sub-dimensions:

1. Pain Perception, Duration, and History

This sub-dimension captures the chronological progression, anatomical extent, and perceived subjective severity of pain. While acute pain reflects tissue irritation or micro-trauma, a high frequency of prior recurrent back pain episodes (Item 8) and extended duration of the current complaint (Item 5) denote an underlying vulnerability to central neuroplastic sensitization and learned helplessness. Pain severity (Item 4) assesses the individual’s baseline sensory intensity, which establishes the experiential load against which coping mechanisms must operate.

2. Psychological Distress and Emotional Vulnerability

Emotional distress is operationalized through the measurement of generalized anxiety, somatic tension, and depressive affect over the preceding week (Items 9 and 10). Depression and anxiety exert profound neuromodulatory effects on descending pain-inhibitory pathways, magnifying nociceptive signaling. Psychologically, elevated depressive affect compromises an individual’s active coping resources, fosters feelings of demoralization, and diminishes outcome expectancies, creating an emotional landscape ripe for symptom persistence.

3. Fear-Avoidance Beliefs and Cognitive Appraisals

This critical domain evaluates the patient’s catastrophic misinterpretations of pain signals. Rooted in cognitive-behavioral constructs, items evaluate the belief that pain is an absolute indicator of tissue harm requiring complete cessation of activity until resolution (Item 13), the conviction that regular work tasks are contraindicated in the presence of discomfort (Item 14), and the expectation that physical activity inherently exacerbates physical injury (Item 15). Furthermore, cognitive self-prognostication is probed via Item 11 (perceived risk of pain becoming persistent or chronic) and Item 12 (anticipated probability of gainful employment in six months). These cognitive appraisals dictate whether pain is met with confronting and active problem-solving or avoidance and behavioral withdrawal.

4. Perceived Functional Capacity and Activities of Daily Living

Functional self-efficacy is gauged across a battery of basic physical and domestic activities, including light work, walking, household chores, grocery shopping, uninterrupted sleep, leisure participation, and prolonged sitting (Items 17 through 23). This domain reflects the patient’s perceived functional impairment rather than objective physiological capacity. An elevated score signifies widespread behavioral deconditioning and an exaggerated subjective appraisal of physical incompetence.

5. Environmental and Occupational Attribution

Assessed via Item 16 (“My pain was caused by an accident at work”), this construct examines attributional style and contextual grievance. Attributing physical symptoms directly to an occupational incident is frequently intertwined with contentious compensation claims, externalized blame, diminished agency, and reduced motivation to return to the offending work environment, all of which correlate powerfully with delayed rehabilitation outcomes.

Theoretical Framework

The Acute Low Back Pain Screening Questionnaire is fundamentally anchored within the Biopsychosocial Model of Medicine, formulated by George L. Engel (1977) and systematically operationalized in spinal disorders by Gordon Waddell (1987). Under this paradigm, pain is conceptualized not merely as a neurophysiological transmission of nociception from damaged peripheral tissues, but as an emergent, complex perceptual phenomenon shaped by cognitive processing, emotional states, behavioral reinforcement, and sociocultural environments. The biomedical model assumes a linear relationship between anatomical pathology and disability; the biopsychosocial model demonstrates that while pathology initiates the pain experience, psychological and behavioral factors govern the subsequent severity and duration of functional impairment.

A second foundational pillar is the Fear-Avoidance Model of Musculoskeletal Pain, articulated extensively by Johan W. S. Vlaeyen, Steven J. Linton, and colleagues (2000). According to this cognitive-behavioral formulation, when an individual experiences acute musculoskeletal injury, they make an initial cognitive appraisal. If the pain is perceived as non-threatening, the patient engages in confrontation, maintaining functional movement, which promotes physiological healing and rapid functional recovery. Conversely, if pain is catastrophically misinterpreted as an immediate sign of structural deterioration, pain-related fear ensues:

• Catastrophizing: Extreme negative appraisals of pain (“this pain is destroying my body”).
• Kinesiophobia: Fear of movement and physical reinjury.
• Avoidance Behavior: Withdrawal from occupational, recreational, and basic physical activities.
• Hypervigilance: Attentional scanning for bodily sensations, which lowers somatic detection thresholds.
• Disuse, Depression, and Disability: Musculoskeletal deconditioning, loss of reinforcing social contact, development of secondary depressive symptoms, and reinforced chronic sick-role behaviors.

Finally, the ALBPSQ incorporates Social Cognitive Theory and the construct of perceived self-efficacy advanced by Albert Bandura (1977). Self-efficacy refers to an individual’s subjective confidence in their capacity to execute courses of action necessary to manage prospective situations. In the ALBPSQ, functional self-efficacy is assessed via items examining perceived capability to work, walk, sleep, and engage in chores despite ongoing discomfort. Low self-efficacy beliefs predict early behavioral surrender, treatment non-compliance, and functional decline.

Validity

The psychometric validity of the ALBPSQ has been subjected to rigorous evaluation across diverse international cohorts, healthcare settings, and cultural translations.

Predictive Validity

Predictive validity is the cornerstone of the ALBPSQ’s utility. In the seminal study by Linton and Halldén (1998) involving 142 primary care patients with acute spinal pain, total scores significantly predicted future sick leave, healthcare utilization, and self-reported functional limitations. Patients scoring above 105 points had an odds ratio exceeding 4.0 for failing to return to work at six-month follow-up compared to those scoring below 105. Using an empirical cut-off score of 105, the instrument correctly classified 88% of patients who took more than 30 days of sick leave, demonstrating a sensitivity of 89% and a specificity of 65%.

Hurley and colleagues (2001) assessed the instrument within an independent clinical trial of 115 acute low back pain patients in the United Kingdom. Receiver Operating Characteristic (ROC) curve analyses revealed an Area Under the Curve (AUC) ranging between .82 and .88 for predicting work absenteeism and persistent functional disability at 12 months. When applying a slightly higher cut-off threshold of 112 points, sensitivity was recorded at 74% with a heightened specificity of 79%, demonstrating robust prognostic capacity across independent healthcare jurisdictions.

Construct, Convergent, and Discriminant Validity

Convergent validity has been established through moderate-to-high bivariate correlations between ALBPSQ sub-domains and validated unidimensional gold-standard instruments:

• Disability: Strong positive correlations with the Roland-Morris Disability Questionnaire (RMDQ; r = .60 to .75) and the Oswestry Disability Index (ODI; r = .62 to .78).
• Fear-Avoidance: Moderate to high correlations with the Fear-Avoidance Beliefs Questionnaire (FABQ) work scale (r = .52 to .68) and physical activity scale (r = .48 to .61), as well as the Tampa Scale for Kinesiophobia (TSK; r = .55 to .70).
• Affective Distress: Statistically significant correlations with the Beck Depression Inventory (BDI; r = .45 to .58) and the Hospital Anxiety and Depression Scale (HADS; r = .50 to .62).

Discriminant validity is evidenced by the scale’s ability to differentiate between acute benign pain trajectories and complex pain presentations complicated by systemic psychosocial pathology, where physical diagnostic tests (such as range of motion or straight leg raise) show negligible discriminatory capacity (r < .20).

Reliability

Reliability evaluations demonstrate that the ALBPSQ possesses strong measurement precision, stability, and internal coherence across varied clinical settings.

Internal Consistency

In the original developmental cohort by Linton and Halldén (1998), the internal consistency of the 21 scored items yielded a Cronbach’s alpha coefficient (α) of .82. Subsequent cross-cultural adaptations have corroborated this finding. The Dutch version by Kole-Snijders et al. (2000) demonstrated a Cronbach’s alpha of .84. An Australian clinical evaluation by Dunstan et al. (2005) reported an overall alpha of .88, confirming that while the instrument covers diverse biopsychosocial domains, the items measure a coherent underlying construct of disability risk without excessive item redundancy.

Test-Retest Reliability and Measurement Error

The temporal stability of the questionnaire has been evaluated among clinically stable cohorts over retest intervals spanning 48 hours to two weeks. Linton and Halldén (1998) recorded a test-retest correlation coefficient (Pearson’s r) of .83 over a 24-to-48-hour window. Subsequent studies utilizing modern Intraclass Correlation Coefficients (ICC, model 2,1) have documented ICC values ranging from .83 (Hurley et al., 2001) to .94 (Kole-Snijders et al., 2000), indicating outstanding reproducibility.

The Standard Error of Measurement (SEM) for the total score has been established across clinical studies between 8.5 and 11.2 points. The corresponding Minimal Detectable Change (MDC at the 95% confidence level) approximates 24 to 28 points on the 210-point scale. This standard indicates that changes in an individual patient’s total score exceeding 28 points reflect true clinical shift rather than measurement noise or stochastic variation.

Factor Analysis

Structural evaluations using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have shed light on the latent architecture of the ALBPSQ. Although conceived as a single composite risk index, the scale is unequivocally multidimensional.

Exploratory Factor Solutions

Principal Component Analyses (PCA) with varimax and oblimin rotations reported in foundational literature (Linton & Halldén, 1998; Kole-Snijders et al., 2000; Hockings et al., 2008) have consistently yielded between five and six distinct empirical factors with eigenvalues exceeding 1.0, collectively accounting for 54% to 64% of total variance:

• Factor 1: Activities of Daily Living and Functional Capacity (Items 17, 18, 19, 20, 21, 22, 23). Demonstrates the highest explained variance (typically 20-25%), with factor loadings ranging from .58 to .82.
• Factor 2: Fear-Avoidance Beliefs and Work Attitudes (Items 13, 14, 15). Items load strongly between .62 and .79, clustering around the cognitive misinterpretation of pain as harm and work contraindication.
• Factor 3: Return-to-Work and Chronicity Expectancies (Items 11, 12, and often 6). Reflects cognitive outcome expectations, with factor loadings between .64 and .85.
• Factor 4: Affective Distress and Emotional State (Items 9 and 10). Tense/anxiety and depression items load tightly together, with loadings between .74 and .84.
• Factor 5: Pain Severity and History (Items 4, 5, 8, and 24). Captures sensory pain load, episode chronicity, and pain-related interference, with factor loadings ranging from .48 to .71.

Confirmatory Factor Analysis and Structural Equation Modeling

Confirmatory Factor Analyses evaluating higher-order structural models have demonstrated that a hierarchical model—featuring a broad second-order “psychosocial risk of chronic disability” factor subsuming the correlated first-order factors—demonstrates acceptable goodness-of-fit. Representative fit indices reported across clinical studies indicate a Comparative Fit Index (CFI) of .91 to .94, a Tucker-Lewis Index (TLI) of .90 to .93, and a Root Mean Square Error of Approximation (RMSEA) of .058 to .068 (90% CI: .049–.077), supporting the empirical justification of summing the individual items into a single, global prognostic score.

Instrument / Measurement Tool

The Acute Low Back Pain Screening Questionnaire is a standardized clinical questionnaire. The full instrument specifications are detailed below:

• Test Type: Multidimensional biopsychosocial screening instrument / self-report prognostic questionnaire.
• Administration Format: Paper-and-pencil questionnaire, clinician-guided structured interview, or computerized/digital online self-assessment.
• Administration Time: Approximately 5 to 10 minutes to complete; approximately 2 minutes to score manually.
• Target Population: Adult patients (18–65 years) and older adults presenting in primary care, occupational health, orthopedics, or physical therapy with acute or subacute low back pain of less than 12 weeks duration.
• Item Count: 24 items total (3 administrative/demographic background items; 21 scored items).
• Response Format:
  • Items 1–3: Administrative/demographic data (Item 1 is a pain anatomical body chart; Item 2 is gender; Item 3 is chronological age). These items are not scored.
  • Item 4: 11-point numeric rating scale (0 to 10) for pain intensity over the past week (0 = “No pain” to 10 = “Pain as bad as it could be”).
  • Item 5: 10 categorical duration brackets representing current pain duration (scored 1 to 10 points: 0–1 week = 1, 1–2 weeks = 2, 3–4 weeks = 3, 4–5 weeks = 4, 6–8 weeks = 5, 9–11 weeks = 6, 3–6 months = 7, 6–9 months = 8, 9–12 months = 9, over 1 year = 10).
  • Item 6: 11-point scale for ability to perform light work tasks (0 = “Completely able” to 10 = “Completely unable”).
  • Item 7: Physical exercise hours per week (10 categorical bands, scored 10 to 0: > 10 hours = 0, 7–10 hours = 2, 4–6 hours = 4, 2–3 hours = 6, 1–2 hours = 8, 0 hours = 10).
  • Item 8: Recurrent episodes of back pain (10-point scoring scale based on episode count: 0 episodes = 0, 1 episode = 2, 2–3 episodes = 6, > 4 episodes = 10).
  • Items 9–15: 11-point numeric rating scales (0 to 10) assessing tension/anxiety, depression, perceived risk of chronicity, work expectancy in 6 months, activity cessation beliefs, work avoidance beliefs, and exercise avoidance beliefs.
  • Item 16: Attribution to work accident (0 = “Completely disagree” to 10 = “Completely agree”).
  • Items 17–23: 11-point functional capacity rating scales (0 = “Completely agree” to 10 = “Completely disagree”).
  • Item 24: 11-point scale for overall pain interference with daily activities (0 = “Not at all” to 10 = “Extremely”).
• Scoring and Inversion Rules:
  • Items 1, 2, and 3 are demographic background variables and are strictly excluded from mathematical score summation.
  • The remaining 21 items (Items 4 through 24) yield an individual score ranging from 0 (or 1) to 10.
  • Total Score Range: Theoretical minimum is 0 (or 2 depending on baseline categories); theoretical maximum is 210 points.
  • Reverse Scoring: All items are aligned such that higher numeric scores uniformly represent elevated psychological distress, greater functional limitation, stronger maladaptive beliefs, and a worse clinical prognosis. Consequently, items phrased positively in terms of functional ability (Items 17, 18, 19, 20, 21, 22, 23) are scored so that “Completely agree” = 0 and “Completely disagree” = 10. Note that in certain specific adaptations (such as the Dutch translation), scoring conventions meticulously verify that Items 16, 17, and 24 adhere to this directionality.
• Clinical Cut-Off Points and Risk Stratification:
  • Low Risk (≤ 90 points): Favorable prognosis. High probability of spontaneous recovery without specialized intervention. Patient should receive positive reassurance, educational advice, and guidance to stay active.
  • Moderate / Intermediate Risk (91–105 points): Intermediate prognosis. Monitor closely; provide primary care physical therapy focusing on progressive functional reactivation.
  • High Risk (> 105 points; conservative threshold > 112 points): High risk of long-term work absenteeism and persistent musculoskeletal disability. Immediate indication for multidisciplinary stepped care, targeted cognitive-behavioral physical rehabilitation, and workplace-oriented intervention.

Permissions & Fee and Test Year

The Acute Low Back Pain Screening Questionnaire was initially constructed and validated in 1998 by Steven J. Linton and Kim Halldén at Örebro University, Sweden. As a foundational public health and clinical research instrument, the original questionnaire is widely accessible within the public domain and clinical literature for non-commercial academic research, educational use, and direct patient care without obligatory royalty fees or licensing charges.

Commercial reproduction, incorporation into commercial digital health systems, or distribution within proprietary medical software applications generally requires permission or appropriate citation of the copyright holders and foundational publications. Researchers and clinical institutions utilizing the instrument are expected to cite the seminal 1998 developmental publication (Accident Analysis & Prevention / Spine) and the corresponding linguistic adaptation (e.g., Kole-Snijders et al., 2000, for Dutch implementations). Clinicians and research teams seeking verified original versions or translation authorization may contact the Center for Health and Medical Psychology (CHAMP) at Örebro University.

References

• Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191–215. https://doi.org/10.1037/0033-295X.84.2.191
• Dunstan, D. A., Covic, T., & Tyson, G. A. (2005). What does the Örebro Musculoskeletal Pain Screening Questionnaire measure? The Clinical Journal of Pain, 21(6), 525–532. https://doi.org/10.1097/01.ajp.0000173017.47209.7d
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. https://doi.org/10.1126/science.847460
• Hockings, R. L., McAuley, J. H., & Maher, C. G. (2008). A systematic review of the predictive ability of the Örebro Musculoskeletal Pain Questionnaire. Spine, 33(15), E494–E500. https://doi.org/10.1097/BRS.0b013e31817ba3b5
• Hurley, D. A., Dusoir, T. E., McDonough, S. M., Moore, A. P., & Baxter, G. D. (2001). Biopsychosocial screening questionnaire for patients with low back pain: Preliminary properties of an Irish version. Physiotherapy, 87(5), 244–245.
• Hurley, D. A., Dusoir, T. E., McDonough, S. M., Moore, A. P., Linton, S. J., & Baxter, G. D. (2000). How is low back pain screening questionnaire predictive of return to work? Journal of Bone and Joint Surgery – British Volume, 82-B(Suppl III), 241.
• Kole-Snijders, A. M. J., Sillen, W., Willen, A., Heuts, P. H. T. G., & Vlaeyen, J. W. S. (2000). De Acute Lage Rugpijn Screenings Vragenlijst (ALBPSQ): Handleiding en Psychometrische Eigenschappen [The Acute Low Back Pain Screening Questionnaire: Manual and Psychometric Properties]. Hoensbroek: Revalidatiecentrum Limburg / Universiteit Maastricht.
• Linton, S. J., & Boersma, K. (2003). Early identification of patients at risk of developing a persistent back problem: The predictive validity of the Örebro Musculoskeletal Pain Questionnaire. The Clinical Journal of Pain, 19(2), 80–86. https://doi.org/10.1097/00002508-200303000-00002
• Linton, S. J., & Halldén, K. (1998). Can we screen for problematic back pain? A screening questionnaire for predicting outcome in acute and subacute back pain. The Clinical Journal of Pain, 14(3), 209–215. https://doi.org/10.1097/00002508-199809000-00007
• Vlaeyen, J. W. S., & Linton, S. J. (2000). Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain, 85(3), 317–332. https://doi.org/10.1016/S0304-3959(99)00242-0
• Waddell, G. (1987). 1987 Volvo award in clinical sciences: A new clinical model for the treatment of low-back pain. Spine, 12(7), 632–644. https://doi.org/10.1097/00007632-198709000-00002

13. Items of the Scale (Questionnaire)